# K071428: INQU

- Pathway: 510(k) (Traditional)
- Applicant: Isto Technologies, Inc.
- Decided: Sep 17, 2007 after 117 days
- Product code: MQV (Filler, Bone Void, Calcium Compound)
- Device class: 2
- Regulation: 21 CFR 888.3045
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
Longest line of descent: 5 generations back to K960978 (1996). 6 ancestors in all.
11 later devices descend from it; 2 cite it directly.
0 of 18 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- K063359: INQU, Isto Technologies, Inc. (2007) Summary page 1.

## Most influential descendants
- K103799: Inqu Paste Mix Plus (2011), 9 descendants of its own
- K130392: Kinex Bioactive (2013), 8 descendants of its own
- K173008: SCS 17-01 (2017), 4 descendants of its own
- K190956: SCS 17-01 (2020), 3 descendants of its own
- K212083: Tactoset Injectable Bone Substitute (2021), 2 descendants of its own

## Indications for use
InQuTM is a resorbable bone void filler intended to fill bony gaps or voids that are not intrinsic to the stability of the bony structure. InQu TM is intended for use as a bone graft substitute in the skeletal system (extremities and pelvis). InQuTM is indicated for use as a bone graft extender in the spine when combined with bone autograft. These defects may be surgically created or result from traumatic injury to the bone.

Source page: https://510kreport.com/device/K071428
Methodology: https://510kreport.com/methodology